Canadian Retina & Vitreous Society

Retinal Vascular Diseases and Basic Science

Monday, June 22
Harbour A, 0800–0930

Objectives
At the end of this session, participants will be able to:

  • integrate new approaches to the management of retinal vascular diseases into their practice
  • assess new advances in basic science research in the area of retinal disease
  • compare new animal models and imaging techniques for the retina and retinal diseases

Guest
Joan Miller, MD

Moderator
Peter Kertes

0800 Neuroprotection for retinal disease
Joan Miller
0815 Discussion
0820 Quantitatively modeling ocular drug flow using micro-CT acquired images
Corey A. Smith, Timothy A Newson, Kevin Leonard, David Holdsworth, Chris Norley, Joesph Barfett, Cindy Hutnik, Kathleen A. Hill
0825 Improved imaging with the hand-held spectral domain ocular coherence tomography and surgical visualization with the intraocular endoscope in the management of advanced retinopathy of prematurity
Rajeev H. Muni, Thomas C. Lee
0830 Discussion
0834 Structural and functional correlates of diabetic macular edema using OCT, microperimetry and multifocal ERG
Stuart G. Coupland, Danah Al-Breiki, Bernard Hurley, Brian C. Leonard
0839 Anesthetic and pharmacological agents alter the optic nerve head component (ONHC) of the porcine multifocal electroretinogram (mfERG)
Rita Buffa, Aphrodite Dracopoulos, Shelley R. Boyd
0844 Discussion
0849 The Renin-Angiotensin System (RAS) induces Erythropoietin (Epo) expression in the mRen(2) transgenic rat retina: implications for diabetic retinopathy
Shelley R. Boyd, Xu Zhao, Hai Wang
0854 Ocular phenotyping in a memantine-treated mouse model of retinal degeneration
Thomas C. MacPherson, Kevin C. Leonard, Cindy M. Hutnik, Kathleen A. Hill
0859 Discussion
0904 In vitro bovine lens toxicity model for testing novel intraocular dyes for chromovitrectomy
Lisa M. Lagrou, John R. Gonder, David McCanna, Jacob G. Sivak
0909 Photodynamic therapy with Verteporfin for chronic central serous chorioretinopathy
Patrick Gooi, Tom Gonder, Amin Kherani, Geoff Williams
0914 Oral versus topical diclofenac for pain prevention during panretinal photocoagulation
Peter A. Zakrzewski, Heather L. O’Donnell, Wai-Ching Lam
0924 Discussion


Age-related Macular Degeneration and Choroidal Neovascularization

Monday, June 22
Harbour A, 1330–1500

Objectives
At the end of this session, participants will be able to:

  • integrate new approaches to choroidal neovascularization into practice
  • describe potential side effects and complications related to anti-VEGF therapies
  • compare new imaging modalities for age-related macular degeneration (AMD)

Guest
Joan Miller, MD

Moderator
Jean-Daniel Arbour

1330AMD: Genetics update
Joan Miller
1345 Discussion
1350 The harlequin carrier mouse (hqX): A new model for aging-associated retinal degeneration
Alex M. Laliberte, Thomas M. MacPherson, Anita Prtenjaca, Cindy M. Hutnik, Kathleen A. Hill
1355 The efficacy of Ranibizumab in the treatment for exudative age-related macular degeneration in patients previously treated by other modalities
Jonathan J. Bastian, Matt Regan, Amber Sheikh, Ravi Nrusimhadevera, Kevin Colleaux
1400 Discussion
1404 Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: A retrospective consecutive case series
Radha P. Kohly, Rajeev H. Muni, Peter J. Kertes, Wai-Ching Lam
1409 Management options for massive hemorrhagic retinal detachment in macular degeneration
Thomas M. Johnson
1414 Discussion
1420 Comparison of OCT vs. Fluorescein angiography for detection of disease activity in treated exudative AMD
Chirag R. Shah, Michael Brent, Wai-Ching Lam, Robert Devenyi, Mark Mandelcorn
1425 Does autofluorescence changes in subfoveal neovascular-AMD have significant correlation with central macular thickness after intravitreal injection of Bevacizumab?
Mohammad Riazi-Esfahani, Hamid Ahmadieh, Mohsen Norouzifard, Niloofar Piri, Alireza Salehi
1430 Discussion
1434 Incidence of ocular complications following intravitreal bevacizumab (Avastin®) injections
Riley Hall, Nidhi Lodha, Patrick Mitchell, Geoff Williams, Amin Kherani
1439 Acute intraocular inflammation following intravitreal injection of bevacizumab - a cluster of cases
Michael P. Fielden, Brian Nelson, R. Geoff Williams, Anna L. Ells, Jag Anand, Amin Kherani
1444 Outbreak of acute intraocular inflammation after bevacizumab intravitreal injection: An epidemiological investigation
Simon Holland, Patrick Ma, David Maberley, Andrew Merkur, David Albiani, Alan Maberley, William Ross
1449 Discussion


Ocular Tumours and Surgical Retina

Monday, June 22
Harbour A, 1530–1700

Objectives
At the end of this session, participants will be able to:

  • describe issues affecting uveal tumor growth
  • apply new knowledge regarding posterior vitreous detachment to practice
  • gain new insight into surgery for macular holes

Guest
Joan Miller, MD

Moderators
Hugh McGowan, Kevin Colleaux

1530 Cellular mechanism of proliferative vitreoretinopathy
Joan Miller
1545 Discussion
1550 Chromosomal 6 aberrations in uveal melanoma and an inflammatory phenotype
Parambir S. Keila, W. Maat, E. S. Jordanova, W. Kroes, Gre P.M. Luyten, Martine J. Jager
1555 Choroidal nevi: Growth assessment and 14 years’ follow-up with ultrasound
Silvin Bakalian, Susan K. Lindley, Jonathan W. Bush, Dina Abdulmannan, Miguel N. Burnier
1600 Discussion
1604 Growth rate of medium-sized uveal melanoma before plaque radiotherapy as a prognostic factor for post-treatment outcome
Hatem Krema, Christine Law, Rand Simpson, David Payne, Charles Pavlin, Wei Xu
1609 Uveal melanomas in young patients
Emiliano Fulda, Bruno Fernandes, Hatem Krema, Rand Simpson
1614 Management of iris melanomas with 125 iodine plaque radiotherapy
Bruno F. Fernandes, Hatem Krema, Emiliano Fulda, Charles V. Pavlin, David G. Payne, E. R. Simpson
1619 Discussion
1625 Anatomic and functional outcomes in patients with repeat surgery for idiopathic full thickness macular holes
Varun Chaudhary, Mark D’Souza, Peter J. Kertes, Robert G. Devenyi, Wai-Ching Lam
1630 Morphological features of phakic and pseudophakic retinal detachments
Mark A. Mandell, Rajeev H. Muni, Steve M. Conti, Feisal A. Adatia, Mir R. Nabavi, Wai-Ching Lam, Robert Devenyi, Peter J. Kertes
1635 Discussion
1639 Signs and symptoms predictive of retinal tear in the setting of posterior vitreous detachment: A meta-analysis
Hussein Hollands, Davin Johnson, David Almeida, Sanjay Sharma
1644 Nevanac in the management of chronic macular edema
Arif Samad, Alison Che
1649 Macular hole in Behcet’s Disease: Clinical features, and outcome of management
Marwan A. Abouammoh, Hassan Al-Dhibi, Manal M. Bouhaimed, Essam Al-Harthi, Imtiaz Chaudhry
1654 Discussion

PDF version of this page


Guest speaker
Joan Miller